TY - JOUR
T1 - Consensus recommendations on mental health issues in Phelan-McDermid syndrome
AU - European Phelan-McDermid syndrome consortium
AU - van Balkom, Ingrid D C
AU - Burdeus-Olavarrieta, Monica
AU - Cooke, Jennifer
AU - de Cuba, A Graciela
AU - Turner, Alison
AU - Vogels, Annick
AU - Maruani, Anna
N1 - © 2023 The Author(s). Published by Elsevier Masson SAS. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
PY - 2023/6/30
Y1 - 2023/6/30
N2 - Phelan-McDermid syndrome is a rare genetic condition caused by a deletion encompassing the 22q13.3 region or a pathogenic variant of the gene SHANK3. The clinical presentation is variable, but main characteristics include global developmental delay/intellectual disability (ID), marked speech impairment or delay, along with other features like hypotonia and somatic or psychiatric comorbidities. This publication delineates mental health, developmental and behavioural themes across the lifetime of individuals with PMS as informed by parents/caregivers, experts, and other key professionals involved in PMS care. We put forward several recommendations based on the available literature concerning mental health and behaviour in PMS. Additionally, this article aims to improve our awareness of the importance of considering developmental level of the individual with PMS when assessing mental health and behavioural issues. Understanding how the discrepancy between developmental level and chronological age may impact concerning behaviours offers insight into the meaning of those behaviours and informs care for individuals with PMS, enabling clinicians to address unmet (mental health) care needs and improve quality of life.
AB - Phelan-McDermid syndrome is a rare genetic condition caused by a deletion encompassing the 22q13.3 region or a pathogenic variant of the gene SHANK3. The clinical presentation is variable, but main characteristics include global developmental delay/intellectual disability (ID), marked speech impairment or delay, along with other features like hypotonia and somatic or psychiatric comorbidities. This publication delineates mental health, developmental and behavioural themes across the lifetime of individuals with PMS as informed by parents/caregivers, experts, and other key professionals involved in PMS care. We put forward several recommendations based on the available literature concerning mental health and behaviour in PMS. Additionally, this article aims to improve our awareness of the importance of considering developmental level of the individual with PMS when assessing mental health and behavioural issues. Understanding how the discrepancy between developmental level and chronological age may impact concerning behaviours offers insight into the meaning of those behaviours and informs care for individuals with PMS, enabling clinicians to address unmet (mental health) care needs and improve quality of life.
KW - Humans
KW - Consensus
KW - Mental Health
KW - Quality of Life
KW - Chromosome Disorders/genetics
KW - Chromosome Deletion
KW - Chromosomes, Human, Pair 22/genetics
U2 - 10.1016/j.ejmg.2023.104770
DO - 10.1016/j.ejmg.2023.104770
M3 - Article
C2 - 37085014
SN - 1769-7212
VL - 66
JO - European journal of medical genetics
JF - European journal of medical genetics
IS - 6
M1 - 104770
ER -